Pfizer’s Centers for Therapeutic Innovation Proposal Portal Opens Sept. 6

The National Center for Advancing Translational Sciences continues to manage NIH’s collaboration with Pfizer’s Centers for Therapeutic Innovation (CTI) network. The next call for proposals opens on Sept. 6; the submission deadline is Oct. 7.

The Pfizer CTI program at NIH is designed to help bridge the gap between early scientific discovery and its translation into new medicines through public-private resource sharing. It pairs leading NIH intramural researchers with Pfizer resources to pursue scientific and medical advances through joint therapeutic development. Goals include identifying biologic compounds with activity in a pathway or target of interest to both NIH and Pfizer and then together moving the compounds into the clinic to test them.

The CTI model is the first NIH-wide biologics initiative with a pharmaceutical partner that NCATS coordinates on behalf of all NIH intramural researchers. For more information, visit https://ncats.nih.gov/cti/proposals and https://ncats.nih.gov/cti. To set up a meeting that can include non-confidential discussion about pre-proposal ideas, contact Pfizer CTI representative Dr. Nader Halim at Nader.Halim@pfizer.com and copy NIH-PfizerCTI@mail.nih.gov.